SAMD9L and myelodysplastic syndrome: Revealing the functionality of SAMD9 and SAMD9L, as well as the impact of their pathogenic mutations, is a critical first step in understanding the development of pediatric MDS and potentially other pediatric hematopoietic disorders characterized by BM hypocellularity, such as BM failure syndromes.